We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Morphofunctional Lung Analysis by Positron Emission Tomography

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00659152
Recruitment Status : Completed
First Posted : April 16, 2008
Last Update Posted : April 28, 2015
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Patients affected by acute lung injury-acute respiratory distress syndrome (ALI-ARDS) undergo a positron emission tomography (PET) scan in order to analyse lung function.

Condition or disease
Acute Lung Injury Acute Respiratory Distress Syndrome

Study Design

Study Type : Observational
Actual Enrollment : 30 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Morphofunctional Lung Analysis by Positron Emission Tomography in ALI-ARDS Patients
Study Start Date : February 2008
Primary Completion Date : December 2013
Study Completion Date : December 2013


Groups and Cohorts

Group/Cohort
1: ALI/ARDS


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
ALI/ARDS ICU patients
Criteria

Inclusion Criteria:

  • Ali-ards
  • Age > 18yrs

Exclusion Criteria:

  • COPD
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00659152


Locations
Italy
Davide Chiumello
Milano, Italy, 201221
Sponsors and Collaborators
Policlinico Hospital
Investigators
Principal Investigator: Davide Chiumello, MD Policlinico Hospital
More Information

Responsible Party: Davide Chiumello, MD, Policlinico Hospital
ClinicalTrials.gov Identifier: NCT00659152     History of Changes
Other Study ID Numbers: 21.02.2008.411
First Posted: April 16, 2008    Key Record Dates
Last Update Posted: April 28, 2015
Last Verified: April 2015

Keywords provided by Davide Chiumello, Policlinico Hospital:
ALI/ARDS

Additional relevant MeSH terms:
Respiratory Distress Syndrome, Newborn
Respiratory Distress Syndrome, Adult
Acute Lung Injury
Lung Injury
Lung Diseases
Respiratory Tract Diseases
Respiration Disorders
Infant, Premature, Diseases
Infant, Newborn, Diseases
Thoracic Injuries
Wounds and Injuries